›› 2010, Vol. 9 ›› Issue (1): 18-24.

• 临床研究 • 上一篇    下一篇

血液透析滤过和高通量透析对β2-微球蛋白清除效果的比较

宋韩明 蔡 砺 吕继成 曹立云 徐 莉 左 力   

  1. 北京大学第一医院肾脏内科暨肾脏病研究所
  • 收稿日期:2009-10-20 修回日期:1900-01-01 出版日期:2010-01-12 发布日期:2010-01-12
  • 通讯作者: 左力

Comparison of hemodiafiltration and high-flux dialysis in the clearance of? microglobulin

SONG Han-ming, CAI Li, LV Ji-cheng, CAO Li-yun, XU Li, ZUO Li.

  

  1. Institute of Nephrology, Peking University First Hopial, Beijing 100034 China
  • Received:2009-10-20 Revised:1900-01-01 Online:2010-01-12 Published:2010-01-12

摘要:

【摘要】目的 β2微球蛋白的蓄积在透析相关淀粉样变(DRA)的发病中起了重要的作用。不同血液净化方式对于β2微球蛋白的清除效果有所不同,低通量透析(LF-HD)对β2微球蛋白几乎没有清除,而血液透析滤过(HDF)和高通量透析(HF-HD)均可有效清除β2微球蛋白。 目的 比较HDF和HF-HD对于β2微球蛋白的清除效果。方法 选取长期稳定的维持性血液透析病人12名,于两周内的同一天分别进行HDF和HF-HD治疗。使用Fresenius-4008S型透析机、HF80S高通量透析器。同一受试者两次试验中,治疗时间、新鲜透析液成分、血流速、透析液流速、抗凝方式等参数相同,HDF采用后稀释法,置换液总量17-25L。于治疗前、治疗第1、2、3小时末、治疗结束时各取血一次,同时于治疗第5、15、30、45、60、90、120、150、180、210、235分钟各取废透析液一次,并定比收集全部废透析液取样。采用放射免疫法检测β2微球蛋白浓度,对各时点血中及透析液中β2微球蛋白浓度(μg/ml)及清除总量(mg)进行配对t检验,P<0.05认为有统计学意义。 结果 受试者中位年龄48.5岁,中位透析龄4年。在HDF过程中,平均脱水量2.47kg,治疗开始前、第1、2、3小时末及治疗结束时血中β2微球蛋白浓度(μg/ml)分别为(57.69±29.61)、(31.20±20.77)、(20.50±14.75)、(13.96±10.02)及(11.29±8.60),在HF-HD过程中平均脱水量2.28kg,上述时间点β2微球蛋白浓度(μg/ml)分别为(53.24±17.65)、(32.12±24.42)、(22.80±14.14)、(22.40±16.54)及(16.00±9.03);上述各指标在HDF和HF-HD无显著性差异(P>0.05)。在HDF和HF-HD,β2微球蛋白的清除总量(mg)分别为(413.34±246.23)和(230.35±134.00),二者有显著性差异(P<0.05);清除率(ml/min)分别为(121.03±49.80)和(86.17±23.33),二者亦有显著性差异(P<0.05)。结论 虽然在治疗的各个时点,接受HDF和HF-HD的病人血中的β2微球蛋白水平未见显著性差异,但在单次治疗过程中,HDF能比HF-HD清除更多的β2微球蛋白。

关键词: 高通量透析, 血液透析滤过, β2微球蛋白, 透析相关淀粉样变

Abstract:

【Abstract】Background Dialysis related amyloidosis (DRA) is a common complication of patients with end stage renal disease. The retention of 2-microglobulin plays an important role in the development of DRA. Different blood purification modalities result in different levels of clearance. Generally speaking, low-flux dialysis(LF-HD) can eliminate little 2-microglobulin during therapy, while hemodiafiltration (HDF) and high-flux dialysis (HF-HD) can clear 2-microglobulin effectively. Objectives To compare the clearance effect of 2-microglobulin between HDF and HF-HD. Methods 12 long-term stable hemodialysis patients were given HDF (post-dilution, with infusion volume 17-25L) and HF-HD respectively in the same day of two weeks. Fresenius-4008 dialysis machines and HF80 high-flux dialyzers were used, while treatment sessions to be compared were carried out in each patient using the same duration, compositions of fresh dialysate, blood flow rate, dialysate/infusate flow rate and anticoagulation protocol. The blood samples were collected just at the beginning, the end of 1st, 2nd, 3rd hour and just before the end of procedure. Meanwhile the waste dialysate samples were collected at the end of 5th, 15th, 30th, 45th, 60th, 90th, 120th, 150th, 180th, 210th, and 235th minute in the same procedure. The total volume of waste dialysate was partially collected from which sample was taken. Radioimmunoassay was used to detect the concentration of 2-microglobulin in blood and dialysate samples. Paired t test was used to compare 2-microglobulin concentration (ug/ml) and total elimination amount (mg). P<0.05 is considered statistically significant. Result The median age of the patients was 48.5yrs, median years of dialysis was 4yrs. During HDF, average fluid removal amount was 2.47kg. The concentrations of 2-microglobulin (ug/ml) just at the beginning, the end of 1st, 2nd, 3rd hour and just before the end of procedure were (57.6929.61), (31.2020.77), (20.5014.75), (13.9610.02) and (11.298.60) respectively. During HF-HD, average fluid removal amount was 2.28kg. The concentrations of 2-microglobulin (ug/ml) just at the beginning, the end of 1st, 2nd, 3rd hour and just before the end of procedure were (53.2417.65), (32.1224.42), (22.8014.14), (22.4016.54) and (16.009.03) respectively. The results above showed no statistically significant differences between HDF and HF-HD (P>0.05). In HDF and HF-HD, total elimination amounts of 2-microglobulin (mg) were (413.34246.23) and (230.35134.00) respectively, which showed statistically significant differences. The clearance rate(ml/min) which were (121.0349.80) and (86.1723.33) respectively for HDF and HF-HD also showed statistically significant differences. Conclusion Although at every time-point in the therapies, blood concentrations of 2-microglobulin showed no significant differences between HDF and HF-HD., HDF can eliminate more 2-microglobulin than HF-HD during a single therapy.
【Key words】

Key words: hemodiafiltration, β2-microglobulin, dialysis-related amyloidosis